LaTasha H. Lee, PhD, MPH is responsible for the oversight and implementation of research projects and programs focused on reducing patient risk and identifying optimal care to reduce health disparities and bring about health equity. She responsible for research partnerships and health equity research at NMQF. Tasha is working on several projects focused on disproportionate COVID-19 rates and outcomes of individuals in communities of color and diversity in clinical research. Prior to joining the NMQF Senior Manager of Partnership Engagement of the Sickle Cell Disease Clinical Trials Network (SCD CTN) at the ASH Research Collaborative. Tasha was tasked with the development of a patient engagement strategy and business plan for this network. Prior to this role she was Senior Manager of Sickle Cell Policy and Programs at American Society of Hematology (ASH) where she was responsible for the day-to-day management of ASH’s Call to Action on Sickle Cell Disease (SCD) a multifaceted initiative focused on legislative or regulatory, global efforts, access to care, and management of the Sickle Cell Disease Coalition. A knowledgeable, skilled and energetic scientist and public policy advisor with experience on Capitol Hill, Dr. Lee has worked very closely with Congress and federal agencies to monitor biomedical research and access to care policy related to various diseases impacting communities of color.